Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Cervical cancer

cervical-mm cancer-types/cervical-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Diagnosis
Loading...

How is cervical cancer diagnosed?

  • Printer-friendly version
  • A|A

If you have HPV infection, it does not mean you have cervical cancer. It takes about 10 to 15 years for cervical cancer to develop, and cervical cancer is a rare outcome.

You may have more tests to confirm a diagnosis of cervical cancer. These may be done if your Cervical Screening Test shows you have:

  • a type of HPV infection that requires further investigation
  • abnormal cells that require treatment
  • symptoms of cervical cancer.

The tests might include a colposcopy, a biopsy, or other types of tests.

Colposcopy

A colposcopy is a procedure that allows the doctor to see a magnified view of the cervix, vagina and vulva. This can help identify where abnormal or changed cells are and what they look like. The doctor will probably also take a tissue sample (biopsy) during the procedure.

The doctor will insert a device called a speculum into your vagina. They will then use an instrument called a colposcope – this looks like a pair of binoculars sitting on a large stand – to view a magnified picture of the cervix, vagina and vulva. The colposcope does not enter your body.

Before the test, the doctor may coat your vagina and cervix with a liquid that will help highlight any abnormal areas. You may experience some mild discomfort during the procedure, which usually takes 10–15 minutes.

Some colposcopes are fitted with a camera, which is connected to a TV screen. This may allow you to watch what the doctor is doing. You should feel free to ask the doctor to explain what is happening.

Biopsy

A biopsy is when your doctor removes some cervical tissue and sends it to the laboratory for examination under a microscope. When the tissue is removed, you may feel uncomfortable for a short time.

Biopsies are usually performed in the examination room or in a clinic. The results should be back from the laboratory within about 1 week.

After a biopsy, you may experience some pain, similar to menstrual cramping. You can ask for medication to relieve the pain. You may also have some bleeding or other vaginal discharge, but these side effects will gradually disappear.

To allow the cervix to heal after a biopsy and to reduce the chance of infection, you should not have sex or use tampons for at least a few days.

Further tests

If the biopsy (or samples taken during treatment for precancerous abnormalities) shows that you have cervical cancer, a number of other tests may be done. These will determine the extent of the cancer in your cervix and whether it has spread (metastasised) to other parts of the body. This is called staging, and will help you and your doctor decide on the best treatment for you.

You may have one or more of the following tests.

Blood tests

You may have blood tests to assess your general health and to help with making decisions about your treatment.

Chest X-ray

Chest X-rays can help identify whether the cancer has spread to the lungs.

Ultrasound1

An ultrasound uses high-energy sound waves to make pictures of body tissues.

CT scan

A computerised tomography (CT) scan is a type of X-ray procedure that takes pictures of the inside of your body. This painless test will help your doctor assess if the cancer has spread to the lymph nodes or to other organs.

You may be given a drink or injection of a liquid (called contrast fluid). This may make you feel hot all over for a few minutes. You may also have a tampon inserted into your vagina before the scan. These will help to give a clearer picture.

A CT scan takes about 5–10 minutes. You will lie flat on a table while the CT scanner, which is large and round like a doughnut, rotates around you and takes a series of pictures.

After the scan, you can usually go home.

People who are allergic to iodine may also be allergic to the dye used in a CT scan. If you think you may have such an allergy, tell your doctor before the scan.

MRI scan2

A magnetic resonance imaging (MRI) scan uses a powerful magnet linked to a computer to take detailed pictures of areas inside the body. The pictures are taken while you lie on a table that slides into a metal cylinder.

An MRI scan is painless, but some people find that lying in the cylinder is noisy and uncomfortably small. You can sometimes request someone in your room for company. If you feel uncomfortable, let your doctor or nurse know – they can give you medication to ease this feeling, and you will usually be given earplugs or headphones.

The scan takes 30–90 minutes, and most people can go home as soon as it is over.

People with a pacemaker or any other metal implant can affect how an MRI works. If you have any metal implants, you should let your doctor know before the scan.

PET scan

You might have a positron emission tomography (PET) scan. PET scans are similar to CT scans – in fact, PET and CT scanners are often combined within the same machine.

Before the scan, you will be injected with a liquid that contains a small amount of radioactive material. This takes 30–60 minutes to spread throughout your body. Cancerous cells will take up more of the liquid than normal cells and will appear brighter in the scan.

The scan itself takes about 30 minutes.2

Examination under general anaesthetic

You may be given a general anaesthetic so your vagina, cervix, bladder and rectum can be carefully examined. A biopsy may also be taken during this examination. The doctor will insert a narrow instrument called a cystoscope into your urethra to examine your bladder. A sigmoidoscope – a tube with a camera attached – may be used to examine your rectum more closely. 

You may also have some of the cells in your uterus removed for examination. The process of removing the lining of the uterus (endometrium) is called a dilation and curettage (D&C). After a D&C, bleeding is common for a few days.

Grading and staging

Knowing the grade and stage of the cancer helps you and your doctors to decide on the most appropriate treatment.

Grading

The grade of a cancer refers to how similar the cancer cells are to normal cells. Low-grade tumours tend to grow more slowly and are usually easier to treat. High-grade tumours grow faster and spread more quickly.

A pathologist grades cervical cancer using cells or tissue from biopsies, and results from imaging and other tests.3

Staging2

The stage of a cancer refers to how far the cancer has spread. The staging system used for cervical cancer is the FIGO system, developed by the International Federation for Gynecology and Obstetrics:

  • Stage 0 (carcinoma in situ): the cancer is confined to the surface layers (cells lining the cervix).
  • Stage I (early or localised cancer): the cancer has grown deeper into the cervix but has not spread beyond it.
  • Stage II (locally advanced cancer): the cancer has spread beyond the cervix and uterus but has not spread to the pelvic wall or lower part of the vagina.
  • Stage III (locally advanced cancer): the cancer has spread to the pelvic wall or the lower part of the vagina. It may also have spread to lymph nodes in the pelvis or abdomen, or has caused a kidney to stop working.
  • Stage IV (metastatic or advanced cancer): the cancer has spread beyond the pelvis, involves the bladder or the rectum or has spread to more distant organs.
  • Last Updated
  • References
  • Relevant Links
updated: 14 September 2022 - 1:08pm
  1. https://www.cancer.gov/types/cervical/patient/cervical-treatment-pdq
  2. https://www.cancer.org.au/assets/pdf/understanding-cervical-cancer-booklet
  3. https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/staged.html
Cancer Council
National Cancer Institute
National Cervical Cancer Screening
American Cancer Society

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia